Cyclooxygenase-2 (COX-2) inhibition and scavenging-free radicals are important targets in cancer treatment. Sulfanylpyrimidines and triazolopyrimidines were synthesized and evaluated as anticancer and antioxidant COX-1/2 inhibitors. Compound showed the same growth inhibitory activity as 5-fluorouracil against MCF-7. Compound displayed broad-spectrum anticancer activity against the four tested cancer cell lines. Compounds and were found to be more active antioxidants than trolox. Compounds and revealed high COX-2 inhibitory activity and selectivity, which was confirmed by docking studies. Compound could be considered as promising anticancer and antioxidant structural lead with COX-2 inhibition that deserve further derivatization and investigation.

Download full-text PDF

Source
http://dx.doi.org/10.4155/fmc-2018-0285DOI Listing

Publication Analysis

Top Keywords

cox-2 inhibition
8
anticancer antioxidant
8
inhibitory activity
8
pyrimidines triazolopyrimidines
4
triazolopyrimidines antiproliferative
4
antiproliferative antioxidants
4
antioxidants cyclooxygenase-1/2
4
cyclooxygenase-1/2 inhibitory
4
inhibitory potential
4
potential cyclooxygenase-2
4

Similar Publications

Anti-inflammatory Effects of the Fucoidan from Sea Cucumber Apostichopus japonicus.

Mar Biotechnol (NY)

January 2025

College of Animal Science and Technology, Northwest A&F University, 22 Xinong Road, Yangling, Xianyang, 712100, Shaanxi, China.

Fucoidan from Apostichopus japonicus (Aj-FUC) has shown anti-inflammatory activity, whereas its mechanism was not explicated. This study investigated the anti-inflammatory potential and mechanism of the fucoidan from green and purple A. japonicus (G-FUC and P-FUC) in lipopolysaccharide (LPS)-treated RAW264.

View Article and Find Full Text PDF

Prostaglandin E2 (PGE-2) is synthesised by cyclooxygenase-2 (COX-2) and microsomal prostaglandin E synthase 1 (mPGES-1). PGE-2 exhibits pro-inflammatory properties in inflammatory conditions. However, there remains limited understanding of the COX-2/mPGES-1/PGE-2 pathway in Angiostrongylus cantonensis-induced meningoencephalitis.

View Article and Find Full Text PDF

Bioengineered NanoAid synergistically targets inflammatory pro-tumor processes to advance glioblastoma chemotherapy.

Nanoscale

January 2025

Department of Anaesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 211101, China.

Through transcriptomic analysis of patient-derived glioblastoma tissues, we identify an overactivation of inflammatory pathways that contribute to the development of a tumor-promoting microenvironment and therapeutic resistance. To address this critical mechanism, we present NanoAid, a biomimetic nanoplatform designed to target inflammatory pro-tumor processes to advance glioblastoma chemotherapy. NanoAid employs macrophage-membrane-liposome hybrids to optimize the delivery of COX-2 inhibitor parecoxib and paclitaxel.

View Article and Find Full Text PDF

Eleutherlene A (), an unprecedented carbon skeleton featuring an aryl-fused 6-methyl-2,7-dioxabicyclo[3.2.1]octane unit, and eleutherlene B (), a naphthoquinone derivative with interesting ring fusion of an α,β-unsaturated γ-lactam and a tetrahydropyran moiety, along with two novel naphthoquinone alkaloids, eleutherlenes C () and D (), were isolated from and identified.

View Article and Find Full Text PDF

Background: Cisplatin is an anti-cancer drug used to treat a plethora of solid tumors. However, it is associated with dose dependent nephrotoxicity limiting its use as anticancer agent.

Objective: The current study aimed to investigate the nephroprotective effect of native Lebanese Cannabis sativa in both in vitro and in vivo mice model of cisplatin-induced nephrotoxicity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!